Prenatal Testing Services
Prenatal DNA testing is a medical procedure that involves analyzing the DNA a developing fetus. This type of testing can provide valuable information about the health and genetic makeup of the fetus, as well as identify any potential genetic disorders or abnormalities. Prenatal DNA testing can be performed through a variety of methods, including amniocentesis chorionic villus sampling.
01
Amnio & CVS Prenatal (Mother, Amnio/CVS sample, & Alleged Father)
This test determines paternity during pregnancy using amniocentesis (Amnio) or chorionic villus sampling (CVS) to collect fetal DNA. The test compares the fetal DNA with the mother's and alleged father's DNA to establish paternity.
03
Non-Invasive Express Testing (Expedites TAT from 7 working days to only 3 working days)
This expedited service reduces the turnaround time for non-invasive prenatal paternity testing from 7 working days to just 3 working days, providing faster results for urgent cases.
05
Non-Invasive Gender (Includes gender of fetus on NIPP test report)
This service includes the gender of the fetus in the non-invasive prenatal paternity (NIPP) test report, providing early knowledge of the baby’s gender in addition to paternity results.
02
Non-Invasive Prenatal (Mother [blood] & Alleged Father [buccal])
This test determines paternity during pregnancy without the need for invasive procedures. It uses a blood sample from the mother and a buccal swab from the alleged father to analyze the fetal DNA circulating in the mother's bloodstream.
04
Additional NIPP Alleged Father (Only applies when additional Alleged Father is collected & tested at the same time as the Mother and 1st Alleged Father)
This service allows for the collection and testing of an additional alleged father during the non-invasive prenatal paternity test. The additional alleged father's DNA will be analyzed alongside the mother's and the first alleged father's DNA.
06
Peekaboo (Stand-alone Early Gender Detection test)
This test is a stand-alone early gender detection service that determines the gender of the fetus as early as 7 weeks into pregnancy, using a simple blood sample from the mother.
